Literature DB >> 8090733

Kinetic intermediates in the reactions between peptides and proteins of major histocompatibility complex class II.

C Beeson1, H M McConnell.   

Abstract

The kinetics of the reactions between fluorescently labeled sperm whale myoglobin-(110-121) peptide and the murine major histocompatibility complex class II protein I-Ed have been analyzed. The presence in solution of both short- and long-lived protein-peptide complexes is demonstrated by the biphasic dissociation of the myoglobin peptide from I-Ed. The formation of the long-lived terminal complex is preceded by a characteristic induction phase. It is shown that the initially formed complex of the myoglobin peptide and I-Ed is a kinetic intermediate that undergoes a unimolecular reaction to form the terminal complex. Reactions between peptides and the class II proteins thus involve an intermediate structurally distinct from the terminal complex. The terminal complex presumably has a structure that is biologically active and similar to the published class II protein-peptide crystal structure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8090733      PMCID: PMC44702          DOI: 10.1073/pnas.91.19.8842

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Free ligand-induced dissociation of MHC-antigen complexes.

Authors:  T Pedrazzini; A Sette; M Albertson; H M Grey
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

2.  Structural intermediates in the reactions of antigenic peptides with MHC molecules.

Authors:  K Dornmair; B Rothenhäusler; H M McConnell
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1989

3.  A first-order reaction controls the binding of antigenic peptides to major histocompatibility complex class II molecules.

Authors:  S N Witt; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

4.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.

Authors:  S Buus; A Sette; S M Colon; C Miles; H M Grey
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

5.  Specific binding of antigenic peptides to separate alpha and beta chains of class II molecules of the major histocompatibility complex.

Authors:  B Rothenhäusler; K Dornmair; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

6.  A kinetic intermediate in the reaction of an antigenic peptide and I-Ek.

Authors:  S Sadegh-Nasseri; H M McConnell
Journal:  Nature       Date:  1989-01-19       Impact factor: 49.962

7.  Structural analysis of peptides capable of binding to more than one Ia antigen.

Authors:  A Sette; S Buus; S Colon; C Miles; H M Grey
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

8.  Autologous peptides constitutively occupy the antigen binding site on Ia.

Authors:  S Buus; A Sette; S M Colon; H M Grey
Journal:  Science       Date:  1988-11-18       Impact factor: 47.728

9.  Antigen presentation by supported planar membranes containing affinity-purified I-Ad.

Authors:  T H Watts; A A Brian; J W Kappler; P Marrack; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

10.  Presentation of antigen by mixed isotype class II molecules in normal H-2d mice.

Authors:  G Ruberti; K S Sellins; C M Hill; R N Germain; C G Fathman; A Livingstone
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  14 in total

1.  Interpretation of biphasic dissociation kinetics for isomeric class II major histocompatibility complex-peptide complexes.

Authors:  T G Anderson; H M McConnell
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

2.  The kinetic basis of peptide exchange catalysis by HLA-DM.

Authors:  J A Zarutskie; R Busch; Z Zavala-Ruiz; M Rushe; E D Mellins; L J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

3.  Dissecting streptavidin-biotin interaction with a laminar flow chamber.

Authors:  Anne Pierres; Dominique Touchard; Anne-Marie Benoliel; Pierre Bongrand
Journal:  Biophys J       Date:  2002-06       Impact factor: 4.033

4.  Biomolecule association rates do not provide a complete description of bond formation.

Authors:  Philippe Robert; Laurent Limozin; Anne Pierres; Pierre Bongrand
Journal:  Biophys J       Date:  2009-06-03       Impact factor: 4.033

5.  Short-lived complexes between myelin basic protein peptides and IAk.

Authors:  K Mason; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

Review 6.  Studying receptor-mediated cell adhesion at the single molecule level.

Authors:  A Pierres; A M Benoliel; P Bongrand
Journal:  Cell Adhes Commun       Date:  1998-07

7.  Specific T cell recognition of kinetic isomers in the binding of peptide to class II major histocompatibility complex.

Authors:  J D Rabinowitz; K Tate; C Lee; C Beeson; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

8.  Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding.

Authors:  H Kropshofer; A B Vogt; G J Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

9.  The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection.

Authors:  Francisco A Chaves; Alvin H Lee; Jennifer L Nayak; Katherine A Richards; Andrea J Sant
Journal:  J Immunol       Date:  2012-03-30       Impact factor: 5.422

10.  Availability of autoantigenic epitopes controls phenotype, severity, and penetrance in TCR Tg autoimmune gastritis.

Authors:  Ditza Levin; Richard J DiPaolo; Carine Brinster; Maria Jamela R Revilleza; Lisa F Boyd; Luc Teyton; Kannan Natarajan; Michael G Mage; Ethan M Shevach; David H Margulies
Journal:  Eur J Immunol       Date:  2008-12       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.